We Think Biotechnology Assets (BME:BST) Has A Fair Chunk Of Debt
Nov 14
Have your own idea? Try our Stock Screener
Spanish (IBEX) Biotech Industry Analysis
UpdatedMar 21, 2025
DataAggregated Company Financials
Companies4
- 7D2.0%
- 3M5.5%
- 1Y30.3%
- YTD3.5%
Over the last 7 days, the Biotech industry has risen 2.2%, driven by gains from Grifols of 1.7%. This means that the industry has gained 38% over the past year. As for the next few years, earnings are expected to grow by 32% per annum.
Industry Valuation and Performance
Has the Spanish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Mar 2025 | €7.6b | €7.4b | €176.3m | 50.7x | 43.3x | 1x |
| Sun, 16 Feb 2025 | €7.5b | €7.2b | €154.7m | 1385.6x | 48.6x | 1x |
| Tue, 14 Jan 2025 | €6.9b | €7.2b | €154.6m | 1062.3x | 44.7x | 1x |
| Thu, 12 Dec 2024 | €6.9b | €7.2b | €154.7m | 1078.8x | 44.8x | 1x |
| Sat, 09 Nov 2024 | €8.5b | €7.2b | €154.8m | 1112.6x | 54.8x | 1.2x |
| Mon, 07 Oct 2024 | €7.4b | €7.0b | €161.7m | 26.9x | 45.6x | 1.1x |
| Wed, 04 Sep 2024 | €7.1b | €7.0b | €165.5m | 26.5x | 42.8x | 1x |
| Fri, 02 Aug 2024 | €6.5b | €7.0b | €161.6m | 25.1x | 40.1x | 0.9x |
| Sun, 30 Jun 2024 | €5.5b | €6.8b | €189.6m | 28.2x | 28.9x | 0.8x |
| Tue, 28 May 2024 | €6.5b | €6.8b | €189.7m | 33.8x | 34x | 0.9x |
| Thu, 25 Apr 2024 | €5.7b | €6.8b | €58.6m | 95.9x | 97.4x | 0.8x |
| Sat, 23 Mar 2024 | €5.4b | €6.8b | €55.1m | 266.2x | 98.4x | 0.8x |
| Mon, 19 Feb 2024 | €7.3b | €6.7b | €31.4m | 175.8x | 231.8x | 1.1x |
| Wed, 17 Jan 2024 | €6.3b | €6.7b | €31.4m | 155.7x | 201.6x | 0.9x |
| Fri, 15 Dec 2023 | €9.4b | €6.7b | €31.5m | 233.3x | 299.3x | 1.4x |
| Sun, 12 Nov 2023 | €7.8b | €6.7b | €31.3m | 189.7x | 247.6x | 1.2x |
| Tue, 10 Oct 2023 | €7.7b | €6.7b | €23.8m | 483.1x | 322.7x | 1.2x |
| Thu, 07 Sep 2023 | €8.3b | €6.7b | €23.8m | 523.3x | 347.8x | 1.2x |
| Sat, 05 Aug 2023 | €8.7b | €6.7b | €23.8m | 540.5x | 365x | 1.3x |
| Mon, 03 Jul 2023 | €7.8b | €6.6b | €69.4m | 94.8x | 112.2x | 1.2x |
| Wed, 31 May 2023 | €7.5b | €6.6b | €69.3m | 92.1x | 108.8x | 1.2x |
| Fri, 28 Apr 2023 | €6.3b | €6.3b | €251.5m | 21.5x | 25.1x | 1x |
| Sun, 26 Mar 2023 | €6.2b | €6.3b | €250.4m | 22.3x | 24.8x | 1x |
| Tue, 21 Feb 2023 | €9.7b | €5.4b | €136.1m | 87.1x | 71.2x | 1.8x |
| Thu, 19 Jan 2023 | €8.7b | €5.5b | €137.1m | 76.9x | 63.1x | 1.6x |
| Sat, 17 Dec 2022 | €7.6b | €5.5b | €137.0m | 66.3x | 55.6x | 1.4x |
| Mon, 14 Nov 2022 | €7.6b | €5.5b | €137.8m | 65.2x | 55x | 1.4x |
| Wed, 12 Oct 2022 | €6.3b | €5.5b | €136.8m | 54.6x | 46.2x | 1.2x |
| Fri, 09 Sep 2022 | €8.2b | €5.5b | €136.8m | 73.6x | 60.2x | 1.5x |
| Sun, 07 Aug 2022 | €9.5b | €5.5b | €136.8m | 86.7x | 69.3x | 1.7x |
| Tue, 05 Jul 2022 | €11.8b | €5.2b | €266.3m | 39.8x | 44.3x | 2.3x |
| Thu, 02 Jun 2022 | €12.6b | €5.2b | €266.4m | 43x | 47.4x | 2.4x |
| Sat, 30 Apr 2022 | €10.9b | €5.2b | €268.5m | 36.8x | 40.5x | 2.1x |
| Mon, 28 Mar 2022 | €10.4b | €5.2b | €268.5m | 35.3x | 38.7x | 2x |
Price to Earnings Ratio
38.7x
Current Industry PE
- Investors are pessimistic on the Spanish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 44.1x which is lower than its 3-year average PE of 105x.
- The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 13% per year over the last three years.
- Meanwhile revenues for these companies have grown 13% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare industry?
| ES Market | 3.55% | |
| Healthcare | 1.49% | |
| Biotech | 2.04% | |
| Biotech | 2.04% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GRF Grifols | €9.40 | 1.7% +€108.9m | 11.6% | PE40.8x | |
| PHM Pharma Mar | €90.10 | 1.9% +€29.0m | 212.6% | PE60.6x | |
| ORY Oryzon Genomics | €3.23 | 13.8% +€25.2m | 83.0% | PS28.4x |